2-[[3-[4-[4-amino-1-(oxan-4-yl)pyrazolo[3,4-d]pyrimidin-3-yl]phenoxy]phenyl]methoxy]benzonitrile
C30H26N6O3 — CID 90075725
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[[3-[4-[4-amino-1-(oxan-4-yl)pyrazolo[3,4-d]pyrimidin-3-yl]phenoxy]phenyl]methoxy]benzonitrile
2-[[3-[4-[4-amino-1-(oxan-4-yl)pyrazolo[3,4-d]pyrimidin-3-yl]phenoxy]phenyl]methoxy]benzonitrile (PubChem CID 90075725) has the molecular formula C30H26N6O3 and a molecular weight of 518.58 g/mol. Its IUPAC name is 2-[[3-[4-[4-amino-1-(oxan-4-yl)pyrazolo[3,4-d]pyrimidin-3-yl]phenoxy]phenyl]methoxy]benzonitrile.
Molecular Properties
| Compound Name | 2-[[3-[4-[4-amino-1-(oxan-4-yl)pyrazolo[3,4-d]pyrimidin-3-yl]phenoxy]phenyl]methoxy]benzonitrile |
|---|---|
| PubChem CID | 90075725 |
| Molecular Formula | C30H26N6O3 |
| Molecular Weight | 518.58 g/mol |
| Exact Mass | 518.21 |
| IUPAC Name | 2-[[3-[4-[4-amino-1-(oxan-4-yl)pyrazolo[3,4-d]pyrimidin-3-yl]phenoxy]phenyl]methoxy]benzonitrile |
| SMILES | N#Cc1ccccc1OCc1cccc(Oc2ccc(-c3nn(C4CCOCC4)c4ncnc(N)c34)cc2)c1 |
| InChI | InChI=1S/C30H26N6O3/c31-17-22-5-1-2-7-26(22)38-18-20-4-3-6-25(16-20)39-24-10-8-21(9-11-24)28-27-29(32)33-19-34-30(27)36(35-28)23-12-14-37-15-13-23/h1-11,16,19,23H,12-15,18H2,(H2,32,33,34) |
| InChIKey | YMCGQQYPSQSBKZ-UHFFFAOYSA-N |
| XLogP | 5.67 |
| TPSA | 121.10 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 39 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 518.58 |
| LogP ≤ 5 | 5.67 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 90075725 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.